Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Oct 6 · above the Ichimoku cloud · RSI 65 · MACD above its signal
None of the 29 investors followed here reported a position in CYAN in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CYAN trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 17.8 | -24.5 | -25.0 | 30.0 | -5.1 | 16.2 | 23.3 | -20.8 | -9.5 | 84.2 | +55.6% | ||
| 2025 | -5.6 | 5.9 | -2.8 | -5.7 | 21.2 | -17.5 | 12.1 | -8.1 | -11.8 | 6.7 | 6.3 | 32.4 | +25.0% |
| 2024 | -13.5 | -61.0 | -3.3 | 58.6 | -32.6 | 6.5 | 112.1 | 11.4 | -2.6 | -17.1 | -44.4 | 2.9 | −59.6% |
| 2023 | 18.2 | -9.2 | -25.4 | 10.2 | 4.1 | -14.9 | -2.3 | -21.4 | 21.2 | -12.5 | 12.9 | 12.7 | −19.1% |
| 2022 | -13.0 | -3.2 | 23.4 | -14.5 | 3.8 | -2.3 | 7.2 | -24.0 | -9.2 | -8.8 | -37.1 | -11.3 | −66.0% |
| 2021 | 22.7 | 1.9 | -13.2 | -4.8 | 0.0 | -3.2 | 0.7 | 3.3 | -8.2 | 5.9 | 15.6 | -8.7 | +6.6% |
| 2020 | 7.0 | -4.1 | -12.3 | 7.3 | -5.0 | 11.0 | -5.6 | 3.6 | 7.5 | 15.5 | 1.8 | 5.6 | +32.8% |
| 2019 | 6.3 | 25.2 | -19.4 | 0.3 | -6.2 | 1.6 | -19.0 | 0.0 | 3.2 | -10.0 | 2.6 | -4.2 | −24.2% |
| 2018 | 1.8 | 30.7 | -1.9 | -17.6 | -6.7 | -0.5 | -6.4 | -2.7 | -5.6 | -2.4 | 11.6 | -17.3 | −22.8% |
| 2017 | -7.0 | 3.8 | -7.2 | -0.8 | -0.5 | -6.6 | -5.6 | 40.3 | -13.6 | 17.0 | -9.7 | -8.9 | −9.1% |
| 2016 | -4.6 | -11.0 | 11.7 | -1.8 | 1.2 | 3.8 | -6.6 | -18.1 | -6.1 | 7.0 | -2.5 | 11.7 | −18.1% |
| 2015 | -6.8 | 26.0 | 3.4 | 8.1 | 3.1 | 1.0 | -14.4 | -10.6 | -18.1 | 0.3 | -2.2 | -9.9 | −24.2% |
| 2014 | 1.6 | 19.8 | -12.7 | -5.0 | -2.6 | -7.2 | 6.7 | 0.0 | -1.9 | 2.5 | 35.4 | 6.0 | +40.6% |
| 2013 | 8.9 | -12.7 | 1.6 | -2.0 | 30.8 | 11.9 | -3.4 | -7.4 | 1.9 | -7.5 | -10.0 | 1.4 | +6.5% |
| 2012 | -5.8 | 23.8 | 24.9 | 1.5 | -27.4 | -7.2 | -1.7 | -14.9 | 1.9 | 1.7 | -12.8 | -11.5 | −33.4% |
| 2011 | -12.7 | 22.0 | -5.0 | -5.6 | 4.6 | 7.7 | -3.3 | 8.2 | -1.3 | 38.3 | 11.5 | 19.8 | +105.6% |
| 2010 | -36.1 | 29.9 | -23.7 | -21.5 | -22.8 | -6.4 | -5.3 | 48.9 | -10.1 | -13.7 | 39.9 | 16.2 | −36.1% |
| 2009 | -2.1 | 36.4 | 3.1 | 3.5 | -1.9 | -3.4 | 1.0 | 20.6 | 10.0 | -9.1 | 48.3 | 48.6 | +262.3% |
| 2008 | -11.4 | 16.9 | 8.3 | 2.5 | 6.8 | -1.2 | -3.5 | 24.4 | -6.9 | -16.3 | -12.6 | 5.0 | +4.3% |
| 2007 | 14.9 | -21.8 | -3.0 | -3.7 | -3.8 | -1.3 | -20.7 | -13.4 | -16.5 | 43.0 | -4.1 | 18.6 | −25.5% |
No insider transactions reported for CYAN.
No analyst coverage for this instrument.
Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction, and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. It operates in the United States, the Asia-Pacific, Europe, and internationally. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.